Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.

Anticancer research - 1 Dec 2011

Kobayashi Masashi, Sonobe Makoto, Takahashi Tsuyoshi, Yoshizawa Akihiko, Ishikawa Masashi, Kikuchi Ryutaro, Okubo Kenichi, Huang Cheng-Long, Date Hiroshi

Abstract excerpt

BACKGROUND: V-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutations are attractive molecular targets for cancer treatment. Detection of BRAF gene mutation and analyses in non-small cell lung cancer (NSCLC) are of great scientific interest. PATIENTS AND METHODS: The study included 581 NSCLC patients (377 males, 204 female) undergoing pulmonary resection. BRAF gene mutations were screened using the PCR-SSCP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Genes, erbB-2

Share to Genes, ras

Share to Polymorphism, Single-Stranded Conformational

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 22199339

Genes

BRAF
EGFR
ERBB2
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.PMID 22199339Read ↗

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.Semantic proximity Read ↗

BRAF-mutations in non-small cell lung cancer.Semantic proximity Read ↗

Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.Semantic proximity Read ↗

A literature review of a meta-analysis of BRAF mutations in non-small cell lung cancer.Semantic proximity Read ↗

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.Semantic proximity Read ↗

Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.Semantic proximity Read ↗

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.Semantic proximity Read ↗

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patientsSemantic proximity Read ↗

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.Semantic proximity Read ↗

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.Semantic proximity Read ↗

[Detection of epidermal growth factor receptor gene mutations and its clinical significance in non-small cell lung cancers].Semantic proximity Read ↗

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.